Elevated filling pressures are associated with poor long-term graft survival after pediatric heart transplantation

Ezgi Yavasca1,2,3, Lisa-Maria Rosenthal1,2,3, Regina Stegherr4

  • 1Deutsches Herzzentrum der Charite Klinik für Angeborene Herzfehler - Kinderkardiologie, Berlin, Germany.

Insights

Elevated filling pressures (EFP) after pediatric heart transplantation (HT) are linked to significantly worse long-term graft survival. Monitoring EFP early post-transplant is crucial for identifying patients at high risk for graft loss.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Pediatric Critical Care

Background:

  • Pediatric heart transplantation (HT) survival has improved.
  • Long-term outcomes beyond 10 years, particularly the impact of elevated filling pressures (EFP), are not well understood.
  • EFP is defined as pulmonary capillary wedge pressure (PCWP) > 15 mmHg and/or right atrial pressure (RAP) > 12 mmHg without biopsy-proven rejection.

Purpose of the Study:

  • To assess the association between early EFP and long-term graft survival in pediatric HT recipients.
  • To investigate the relationship between EFP and cardiovascular adverse events (AE) post-transplant.

Main Methods:

  • Retrospective analysis of 114 pediatric HT cases from 1986-2020.
  • Included patients with PCWP and/or RAP measurements between 7 months and 5 years post-transplant (landmark cohort).
  • Evaluated associations of EFP with graft survival and AE using survival analysis.

Main Results:

  • 12% of grafts (14/114) exhibited EFP during the follow-up period.
  • Grafts with EFP showed significantly worse 10-year survival (44% vs. 85%, p < 0.001) and a higher risk of graft loss (HR 6.04).
  • The incidence of AE was numerically higher in the EFP group, though this finding is exploratory.

Conclusions:

  • Early elevated filling pressures in pediatric heart transplant recipients are associated with poor long-term graft survival.
  • EFP may serve as an indicator for potential cardiovascular complications after HT.
  • Further research is warranted to explore the implications of EFP on cardiovascular adverse events.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...